The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects
Abstract
The purpose of this study was to determine the contribution of the adrenergic system in mediating hypertension in obese and lean patients. Thirteen obese, hypertensive patients with a body mass index (BMI) > or =28 kg/m2 (obese) and nine lean patients with a BMI < or =25 kg/m2 (lean) were recruited. After a 1-week washout period, participants underwent daytime ambulatory blood pressure monitoring (ABPM). Participants were then treated with the alpha-adrenergic antagonist doxazosin, titrating to 4 mg QHS in 1 week. In the next week, the beta-adrenergic antagonist atenolol was added at an initial dose of 25 mg/day and titrated to 50 mg/day within 1 week. One month after the addition of atenolol, all patients underwent a second ABPM session. There were no differences between the obese and lean subjects in baseline systolic (SBP), diastolic (DBP), or mean arterial pressures (MAP) measured by office recording or ABPM. However, obese subjects had higher heart rates than lean subjects (87.5+/-2.4 v 76.8+/-4.9 beats/min). After 1 month of treatment with the adrenergic blockers, obese patients had a significantly lower SBP (130.0+/-2.5 v 138.9+/-2.1 mm Hg, P = .02) and MAP (99.6+/-2.3 v 107.0+/-1.5 mm Hg, P = .02) than lean patients. Obese patients also tended to have a lower DBP than lean patients (84.3+/-2.5 v 90.9+/-1.6 mm Hg, P = .057), but there was no significant difference in heart rate after 1 month of adrenergic blockade. These results indicate that blood pressure is more sensitive to adrenergic blockade in obese than in lean hypertensive patients and suggest that increased sympathetic activity may be an important factor in the maintenance of hypertension in obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, sympathetic blockade in patients with obesity or in experimental animals with dietary-induced obesity consistently reduces BP6,158.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [158]
In the citing paper
“administration of α/β-adrenergic blockers or clonidine, which stimulates central α-2 adrenergic receptors and reduces SNS activity, prevents most of the obesity-induced rise in BP in obese animals10,62 and α/β-adrenergic blockade reduces ambulatory BP significantly more in obese than in lean hypertensive patients63”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [63]
In the citing paper
“One view is that in patients with obesity-hypertension, antiadrenergic antihypertensive drugs should be preferentially used; there is evidence of greater blood pressure lowering in them.105”
From Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form? (2018) · cites this paper as [105]
In the citing paper
“Adrenergic blockade produced a significantly greater decrease in blood pressure in obese vs lean hypertensive patients.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [68]
Citations
Cites
The Relation of Adiposity to Blood Pressure and Development of Hypertension
Kannel, W. B., BRAND, N., SKINNER, J. J., Dawber, T. R., & MCNAMARA, P. M. (1967) · Annals of Internal Medicine · doi:10.7326/0003-4819-67-1-48 · Cited by 815
Incidence and precursors of hypertension in young adults: The Framingham offspring study
Garrison, R. J., Kannel, W. B., Stokes, J., & Castelli, W. P. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90087-9 · Cited by 789
Anderson, E. A., Sinkey, C. A., Lawton, W. J., & Mark, A. L. (1989) · Hypertension · doi:10.1161/01.hyp.14.2.177 · Cited by 632
Sympathetic Activation in Obese Normotensive Subjects
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., Giannattasio, C., Brunani, A., Cavagnini, F., & Mancia, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.560 · Cited by 614
Neural mechanisms in human obesity-related hypertension
Rumantir, M. S., Vaz, M., Jennings, G. L., Collier, G., Kaye, D. M., Seals, D. R., Wiesner, G. H., Brunner-La Rocca, H. P., & Esler, M. D. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917080-00012 · Cited by 396
Pollare, T., Lithell, H., Selinus, I., & Berne, C. (1988) · Diabetologia · doi:10.1007/bf00271585 · Cited by 354
Obesity-induced hypertension. Renal function and systemic hemodynamics.
Hall, J. E., Brands, M. W., Dixon, W. N., & Smith, M. J. (1993) · Hypertension · doi:10.1161/01.hyp.22.3.292 · Cited by 328
Autonomic nervous system activity in weight gain and weight loss
Arone, L. J., Mackintosh, R. M., Rosenbaum, M. S., Leibel, R. L., & Hirsch, J. (1995) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1995.269.1.r222 · Cited by 224
Jones, D. W., Kim, J. S., Andrew, M. E., Kim, S. J., & Hong, Y. P. (1994) · Journal of Hypertension · doi:10.1097/00004872-199412000-00018 · Cited by 191
Obesity, the sympathetic nervous system, and essential hypertension.
Tuck, M. L. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i67 · Cited by 173
Cited by
Sorted by citations
Items 101–183 of 183
Hawkins, D. N., Faler, B. J., Choi, Y., & Prasad, B. M. (2018) · Obesity Surgery · doi:10.1007/s11695-017-3091-x · Cited by 19
Gupta, R. D., Parray, A. A., Kothadia, R. J., Pulock, O. S., Pinky, S. D., Haider, S. S., Akonde, M., & Haider, M. R. (2024) · Clinical Hypertension · doi:10.1186/s40885-023-00257-2 · Cited by 27
Zhang, R., Thakur, V., Morse, S., & Reisin, E. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001496 · Cited by 18
Drug Mechanisms to Help in Managing Resistant Hypertension in Obesity
Jansen, P. M., Danser, J., Spiering, W., & van den Meiracker, A. H. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0123-5 · Cited by 17
Pathophysiology of Obesity—Induced Hypertension and Target Organ Damage
Hall, J. E., da Silva, A. A., Brandon, E. L., Stec, D. E., Ying, Z., & Jones, D. W. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50041-6 · Cited by 18
Clemmer, J. S., Faulkner, J., Mullen, A. J., Butler, K. R., & Hester, R. L. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0238-6 · Cited by 17
The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension
Carnagarin, R., Gregory, C., Azzam, O., Hillis, G. S., Schultz, C. J., Watts, G. F., Bell, D. A., Matthews, V. B., & Schlaich, M. P. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0795-1 · Cited by 17
Pharmacotherapeutic strategies for treating hypertension in patients with obesity
Carnagarin, R., Matthews, V. B., Gregory, C., & Schlaich, M. P. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1458092 · Cited by 20
Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome
Nizar, J. M., & Bhalla, V. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0759-5 · Cited by 17
Holwerda, S. W., Gangwish, M. E., Luehrs, R. E., Nuckols, V. R., Thyfault, J. P., Miles, J. M., & Pierce, G. L. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003335 · Cited by 17
Cardiometabolic crosstalk in obesity-associated arterial hypertension
Jordan, J., & Birkenfeld, A. L. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9348-1 · Cited by 17
Gil, J. S., Drager, L. F., Guerra, G. M., Mostarda, C. T., Irigoyen, M. C., Costa‐Hong, V., Bortolotto, L. A., Egan, B. M., & Lopes, H. F. (2013) · Clinics · doi:10.6061/clinics/2013(12)04 · Cited by 15
Therapeutic Considerations in the Treatment of Obesity Hypertension
Wofford, M. R., Davis, M. M., Harkins, K. G., King, D. S., Wyatt, S. B., & Jones, D. W. (2002) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.00502.x · Cited by 15
Self-citationPrimary hypertension and special aspects of hypertension in older children and adolescents
Ellis, D., & Miyashita (2011) · Adolescent Health Medicine and Therapeutics · doi:10.2147/ahmt.s11715 · Cited by 17
Ambulatory blood pressure monitoring in childhood and adult obesity
Ben‐Dov, I. Z., & Bursztyn, M. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0024-7 · Cited by 14
Lang, D., Nahler, A., Lambert, T., Grund, M., Kammler, J., Kellermair, J., Blessberger, H., Kypta, A., Steinwender, C., & Auer, J. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12844 · Cited by 15
Soluble (Pro)Renin Receptor in Hypertension
Yang, T. (2022) · The Nephron journals/Nephron journals · doi:10.1159/000525635 · Cited by 15
The Association between Morning Hypertension and Metabolic Syndrome in Hypertensive Patients
Tamaki, S., Nakamura, Y., Yoshino, T., MATSUMOTO, Y., Tarutani, Y., Okabayashi, T., KAWASHIMA, T., & Horie, M. (2006) · Hypertension Research · doi:10.1291/hypres.29.783 · Cited by 13
Adipokine Profiling in Adult Women With Central Obesity and Hypertension
Supriya, R., Yung, B. Y., Yu, A. P., Lee, P. H., Lai, C. W. K., Cheng, K. K. Y., Yau, S., Chan, L., Sheridan, S. E., & Siu, P. M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00294 · Cited by 12
Engeli, S., & Jordan, J. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0374-z · Cited by 12
From pathophysiology to novel approaches for obesity-associated hypertension
Kanbay, M., Yayci, E., Genc, C., Çöpür, S., Aktaş, Ö. Y., Sarafidis, P. A., Covic, A. C., Ortíz, A., & Laffin, L. J. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf218 · Cited by 10
Bayauli, P. M., M’Buyamba-Kayamba, J.-R., Lemogoum, D., Fagard, R. H., Degaute, J.-P., Ditu, M., Lepira, B. F., & M’Buyamba-Kabangu, J.-R. (2014) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2014.48049 · Cited by 10
The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity
Parikh, J. S., Randhawa, A. K., Wharton, S., Edgell, H., & Kuk, J. L. (2018) · Journal of Obesity · doi:10.1155/2018/4573258 · Cited by 10
Chronic CNS-mediated cardiometabolic actions of leptin: potential role of sex differences
da Silva, A. A., Pinkerton, M., Spradley, F. T., Palei, A. C., Hall, J. E., & do Carmo, J. M. (2020) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00027.2020 · Cited by 10
Fisiopatología de la hipertensión arterial secundaria a obesidad
Casilimas, G. A. G., Martin, D. A., Martínez‐Ceballos, M. A., Merchán, C. R., Mayorga, C. A., & Barragán, A. F. (2017) · Archivos de cardiología de México · doi:10.1016/j.acmx.2017.02.001 · Cited by 14
Renal Dysfunction in Hypertension and Obesity
Elmarakby, A. A., Pollock, D. M., & Imig, J. D. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00187-5 · Cited by 9
Hypertension in children with obesity
Gunta, S. S. (2014) · World Journal of Hypertension · doi:10.5494/wjh.v4.i2.15 · Cited by 10
Obesity and Metabolic Syndrome Hypertension
Hall, M. E., Wang, Z., do Carmo, J. M., Kamimura, D., & Hall, J. E. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_42 · Cited by 8
Effectiveness of renal denervation in the treatment of hypertension: a literature review
Shah, R. T., & Wang, B. (2022) · Clinical Hypertension · doi:10.1186/s40885-022-00194-6 · Cited by 9
Simonyi, G., & Kollár, R. (2013) · Orvosi Hetilap · doi:10.1556/oh.2013.29738 · Cited by 7
Management of the Hypertensive Child
Ellis, D. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_63 · Cited by 7
Mende, C. W., Giles, T. D., Bharucha, D. B., Ferguson, W., Mallick, M., & Patel, M. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.12965 · Cited by 7
Obesity-Associated Hypertension
Uwaifo, G. I. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_13 · Cited by 7
Obesity prevalence factors associated with sympathetic overactivity and hypertension
Shah, W., Ali, I., Shahid, W., Shoaib, M., Iqbal, A., & Mehmood, A. (2023) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12765 · Cited by 6
Childhood Obesity and Blood Pressure Regulation
Rocchini, A. P. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-824-9_17 · Cited by 6
Vasyuk, Y. A., Dovzhenko, T. V., Dubrovskaya, T. I., Нестерова, Е. А., & Shupenina, E. Y. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.01.200567 · Cited by 5
Chechekhin, V. I., Ivanova, A., Kulebyakin, K. Y., Sysoeva, V., Naida, D. A., Arbatsky, M. S., Basalova, N. A., Karagyaur, M. N., Никитична, С. М., Efimenko, A. Y., et al. (2023) · Cells · doi:10.3390/cells12040585 · Cited by 6
Visceral Fat and Hypertension: Sex Differences
Pausová, Z. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407869-7.00009-x · Cited by 5
Role of the Kidney in Hypertension
Granger, J. P., & Hall, J. E. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50026-x · Cited by 5
Adrenoceptors and Hypertension
Kulkarni, S., & Wilkinson, I. B. (2024) · Handbook of experimental pharmacology · doi:10.1007/164_2024_719 · Cited by 4
Relationship Between Antihypertensive Drugs and Metabolic Syndrome
Wofford, M. R., & King, D. S. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.308 · Cited by 4
Self-citationHypertension in obese children and adolescents
Peco‐Antić, A. (2009) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0902091p · Cited by 4
Bhandari, P., Prakash, V., & Flack, J. M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac072 · Cited by 3
Obesity and Hypertension: Pathophysiology and Treatment
Hall, M. E., Omoto, A. C. M., do Carmo, J. M., da Silva, A. A., & Hall, J. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00037-2 · Cited by 3
Pathophysiology and Optimal Management of Hypertension in Patients with Cardiometabolic Syndrome
Ihm, S. (2021) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2021.1.e3 · Cited by 3
Hypertension artérielle chez les patients obèses : physiopathologie et prise en charge
Girerd, X. J., & Hansel, B. (2009) · La Presse Médicale · doi:10.1016/j.lpm.2009.01.006 · Cited by 3
Role of sympathetic overactivity in the pathophysiology of the metabolic syndrome
Egan, B. M., & Julius, S. (2004) · Dialogues in Cardiovascular Medicine · Cited by 3
Zaragoza-García, Ó., Gutiérrez-Pérez, I. A., Delgado‐Floody, P., Parra‐Rojas, I., Jerez‐Mayorga, D., Campos‐Jara, C., & Guzmán‐Guzmán, I. P. (2022) · International Journal of Hypertension · doi:10.1155/2022/4522493 · Cited by 3
Hypertension prevalence in Iran’s elderly according to new criteria: the Tehran Geriatric Eye Study
Fotouhi, F., Shahidi, A., Hashemi, H., Saffarpour, M., Yekta, A., Esmaieli, R., Esteki, T., Derakhshan, H. B., & Khabazkhoob, M. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01272-8 · Cited by 2
Belly fat and resistant hypertension
Jordan, J., & Grassi, G. M. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328339b8d9 · Cited by 2
The Enhanced Effect of Atenolol on Hypertension in Metabolic Syndrome
Ueno, N., & Satou, Y. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0001 · Cited by 2
Rajapakse, N. W., Karim, F., Evans, R. G., Kaye, D. M., & Head, G. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131424 · Cited by 2
ROLE OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) IN OBESITY-ASSOCIATED HYPERTENSION
Gupte, M. (2011) · UKnowledge (University of Kentucky) · Cited by 2
Dobrescu, M., Păun, D. L., Buculei, S., Ghimigean, A., & Poiană, C. (2022) · Internal Medicine · doi:10.2478/inmed-2022-0199 · Cited by 1
Akhtar, N., Ullah, Z., Khan, M. F., Jain, V. D., Bijani, S., Choudhary, R. K., Ahmad, N., Rizvi, M. R., & Iqbal, D. (2023) · Journal Of Advanced Zoology · doi:10.17762/jaz.v44is-5.1457 · Cited by 1
Precision approaches to paediatric hypertension: linking pathophysiology to therapy
Haseler, E., & Sinha, M. D. (2025) · Pediatric Nephrology · doi:10.1007/s00467-025-07100-w · Cited by 1
Obesity and Hypertension: Impact on Cardiovascular and Renal Systems
Hall, J. E., Jones, D. W., Kuo, J. J., da Silva, A. A., Liu, J., & Tallam, L. S. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0258-5.50134-4 · Cited by 1
Pathogenesis of Hypertension and Renal Disease in Obesity
Hunley, T. E., & Kon, V. (2010) · Springer eBooks · doi:10.1007/978-1-60327-874-4_16 · Cited by 1
Management of the Hypertensive Child
Ellis, D., & Miyashita, Y. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_82 · Cited by 1
Leptin, the Autonomic Nervous System, and Hypertension
da Silva, A. A., do Carmo, J. M., Wang, Z., & Hall, J. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-09915-6_14 · Cited by 1
Obesity-Hypertension Physiopathology and Treatment: A Forty-Year Retrospect
Owen, J., Morse, S., McLean, A., & Reisin, E. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-75310-2_15 · Cited by 1
Obesity-Associated Hypertension
Shibao, C. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-386525-0.00074-3 · Cited by 1
Sympathetic vascular tone in human obesity
Correia, M. (2007) · doi:10.17077/etd.v54kf0if · Cited by 1
Geneidy, A. A., & Solomon, R. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_18 · Cited by 1
Stoffwechseleffekte antihypertensiver Substanzen
Wascher, T. C., Sourij, H., Schmut, E., & Sock, S. (2007) · Journal für Kardiologie (Krause & Pachernegg GmbH)
From Abdominal Adiposity to Hypertension: Mechanisms and Clinical Implications
Rocchini, A. P. (2011) · Wiley eBooks · doi:10.1002/9781444318456.ch33
Hypertension in lean and obese individuals: An evenly or unevenly dangerous condition
Iacobellis, G., & Sharma, A. M. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.06.004
Adaptive Thermogenesis Is Intact in B6 and A/J Mice Studied at Thermoneutrality
Roberts, L. M. (2003)
Артеријска хипертензија гојазне деце и адолесцената
Peco‐Antić, A. (2009)
Effects of Modest Weight Gain on Blood Pressure and Sympathetic Neural Activity in Nonobese Humans
Gentile, C. L. (2006) · VTechWorks (Virginia Tech)
Secondary Causes: Work-Up and Its Specificities in CKD: Influence of Autonomic Dysfunction
Iliescu, R., & Șerban, D. N. (2017) · Springer eBooks · doi:10.1007/978-3-319-56827-0_10
Pathogenesis of Hypertension and Renal Disease in Obese Children
Hunley, T. E., Albaugh, V. L., & Kon, V. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_27
Impact of obesity on hypertension: A review
Abdussalam, A. (2021) · IP Journal of Nutrition Metabolism and Health Science · doi:10.18231/j.ijnmhs.2021.007
Yıldız, B. T., Tunçel, D., & Sokmen, G. (2021) · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · doi:10.17517/ksutfd.951570
Management of the Hypertensive Child
Ellis, D., & Miyashita, Y. (2014) · Springer eBooks · doi:10.1007/978-3-642-27843-3_82-1
Harbuz-Miller, I., Woodman, R., & Lastra, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95896-3
Adverse Childhood Experiences and the Cardiovascular Health of Children: A Cross-Sectional Study
Pretty, C., O’Leary, D. D., Cairney, J., & Wade, T. J. (2015) · Apple Academic Press eBooks · doi:10.1201/b18313-16
A comparative study on obese and non-obese for evaluating the risk of hypertension
Mahmood, S., & Rao, D. S. (2022) · International Journal of Clinical Biochemistry and Research · doi:10.18231/j.ijcbr.2022.040
GASTROPLASTIA COMO MEDIDA TERAPÊUTICA EM PACIENTES OBESOS HIPERTENSOS
Fernandes, I., Filho, H. M. B., Teixeira, T. M., Silva, R. L. J. A., & Ludovico, N. D. (2023) · Revista Brasileira de Hipertensão · doi:10.47870/1519-7522/2023300116-21
Gupta, R. D., Parray, A. A., Kothadia, R. J., Pulock, O. S., Pinky, S. D., Haider, S. S., Akonde, M., & Haider, M. R. (2024) · Figshare · doi:10.6084/m9.figshare.26663020
Obesity-Related Hypertension: A Review of Pathophysiology, Management, and Weight Loss Medications
Allwaif, M., Ahmed, N. S. J. I., Alqahtani, M., Alasmakh, Y., Almuhsen, A., Kehlini, M., Aljeaid, N., Alkhalifa, A., & Alkhater, N. S. (2025) · Studies in systems, decision and control · doi:10.1007/978-3-031-95280-7_35
Metadata
- Authors
- Wofford, M.
- Affiliations
- University of Mississippi Medical Center (US)
- Corresponding author
- Wofford, M
- Venue
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-07
- Volume
- 14
- Issue
- 7
- Pages
- 694-698
- ISSN
- 0895-7061 (ISSN-L)
- OpenAlex
- W2155178368
- Cited by
- 184
- References
- 23
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 6 · 2018: 9 · 2017: 11 · 2016: 7 · 2015: 6 · 2014: 12 · 2013: 8 · 2012: 9
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- DigitalCommons-Cedarville (Cedarville University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- obesity, hypertension, adrenergic blockade, alpha-adrenoceptor antagonism, beta-adrenoceptor antagonism, doxazosin, atenolol, sympathetic activity, ambulatory blood pressure, heart rate
- MeSH terms
- Adrenergic alpha-Antagonists, Adrenergic beta-Antagonists, Adult, Atenolol, Female, Humans, Hypertension, Male, Middle Aged, Obesity, Prospective Studies, Sympathetic Nervous System, Doxazosin, Blood Pressure Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
